Skip to main content
. 2009 Jan 9;329(1):297–305. doi: 10.1124/jpet.108.147751

Fig. 6.

Fig. 6.

[13C]Pantoprazole plasma concentrations (mean ± S.D.) versus time curves in healthy volunteers with CYP2C19*1/*1 (EMs), CYP2C19*1/*2 or CYP2C19*1/*3 (IMs) and CYP2C19*2/*2 (PMs) genotypes after oral administration of a solution consisting of 100 mg of [13C]pantoprazole sodium-sesquihydrate and 2.1 g of sodium bicarbonate.